The American Macular Degeneration Foundation Drives Research and Hope With New Grants
29-Dec-2022 4:05 PM EST
Newswise — Northampton, MA — The American Macular Degeneration Foundation (AMDF) is investing $1.1 million in studies that hold the potential to set new standards in the prevention and treatment of age-related macular degeneration (AMD). The nonprofit announced its expanded slate of grants in the wake of recently released figures that put the number of Americans with some form of the sight stealing disease at 20 million.
Young Investigator Leadership Awards Announced by the American Macular Degeneration Foundation
Northampton, MA 7-May-2021 — The American Macular Degeneration Foundation (AMDF) is launching a new category of award designed to cover essential costs for young investigators as they pursue careers in vision research.
New Procedure Improves Vision In Those With Macular Degeneration
Study Receives Grant Support From American Macular Degeneration Foundation
Northampton, MA 4-May-2021 — The American Macular Degeneration Foundation (AMDF) is supporting the next phase of clinical testing of Corneal Photovitrification (CPV), a new corneal laser procedure for vision improvement in patients with late-stage, dry or wet age-related macular degeneration and other retinal disorders. Previous clinical studies have shown the painless procedure allows patients to regain several lines of useful vision, to read again, and to experience improved quality of life.
The American Macular Degeneration Foundation Partners with Fight for Sight to Offer Summer Student Research Fellowships
Northampton, MA 15-Jul-2019 – The American Macular Degeneration Foundation (AMDF) is continuing its partnership with Fight for Sight (FFS) to co-fund two AMD-focused Summer Student Fellowships in 2019.
Cutting-Edge Research Grants Announced by The American Macular Degeneration Foundation
Co-funded with Research to Prevent Blindness
Northampton, MA 24-Jun-2019 – The American Macular Degeneration Foundation (AMDF), in partnership with Research to Prevent Blindness (RPB), has announced the recipients of the RPB/AMDF Catalyst Awards for Innovative Research Approaches for Age-Related Macular Degeneration, which provide seed money for high-risk/high-gain AMD research into both dry and wet forms of the disease. Each grantee will receive $300,000, payable across three years, pending a mid-point review.